Abstract:Urine is a noninvasive biofluid that is rich in polar metabolites and well suited for metabolomic epidemiology. However, because of individual variability in health and hydration status, the physiological concentration of urine can differ >15-fold, which can pose major challenges in untargeted liquid chromatography-mass spectrometry (LC-MS) metabolomics. Although numerous urine normalization methods have been implemented (e.g., creatinine, specific gravity-SG), most are manual and, therefore, not practical for population-based studies. To address this issue, we developed a method to measure SG in 96-well-plates using a refractive index detector (RID), which exhibited accuracy within 85-115% and <3.4% precision. Bland-Altman statistics showed a mean deviation of -0.0001 SG units (limits of agreement: -0.0014 to 0.0011) relative to a hand-held refractometer. Using this RID-based SG normalization, we developed an automated LC-MS workflow for untargeted urinary metabolomics in a 96-well-plate format. The workflow uses positive and negative ionization HILIC chromatography and acquires mass spectra in data-independent acquisition (DIA) mode at three collision energies. Five technical internal standards (tISs) were used to monitor data quality in each method, all of which demonstrated raw coefficients of variation (CVs) < 10% in the quality controls (QCs) and < 20% in the samples for a small cohort (n = 87 urine samples, n = 22 QCs). Application in a large cohort (n = 842 urine samples, n = 248 QCs) demonstrated CVQC < 5% and CVsamples < 16% for 4/5 tISs after signal drift correction by cubic spline regression. The workflow identified >540 urinary metabolites including endogenous and exogenous compounds. This platform is suitable for performing urinary untargeted metabolomic epidemiology and will be useful for applications in population-based molecular phenotyping.

Ultrasensitive and High Reproducible Detection of Urinary Metabolites Using the Tip–Contact Extraction Method Coupled with Negative LDI-MS

Profiling of Urine Carbonyl Metabolic Fingerprints in Bladder Cancer Based on Ambient Ionization Mass Spectrometry

Biofluids Metabolic Profiling Based on PS@Fe 3 O 4 –NH 2 Magnetic Beads-Assisted LDI-MS for Liver Cancer Screening

UPLC-Q-TOF/MS-based Urine Metabolomics for the Diagnosis and Staging of Bladder Cancer

Study on Urinary Metabonmics Using Rapid Resolution Liquid Chromatography Tandem Mass Spectrometry

Investigation of Urinary Exosome Metabolic Patterns in Membranous Nephropathy by Titania‐Assisted Intact Exosome Mass Spectrometry

Self-Assembled Hyperbranched Gold Nanoarrays Decode Serum United Urine Metabolic Fingerprints for Kidney Tumor Diagnosis.

Flexible Point-of-Care Electrodes for Ultrasensitive Detection of Bladder Tumor-Relevant Mirna in Urine

TA@Au Nanoflower-assisted Laser Desorption/Ionization Mass Spectrometry for Metabolite Detection

Strand displacement amplification-coupled dynamic light scattering method to detect urinary telomerase for non-invasive detection of bladder cancer.

Matrix- and Surface-Assisted Laser Desorption/Ionization Mass Spectrometry Methods for Urological Cancer Biomarker Discovery—Metabolomics and Lipidomics Approaches

Urine Metabolic Fingerprints Encode Subtypes of Kidney Diseases.

Exploratory urinary metabolic biomarkers and pathways using UPLC-Q-TOF-HDMS coupled with pattern recognition approach

Pressurized CEC coupled with QTOF-MS for urinary metabolomics.

Urine Metabolic Profiling for Rapid Lung Cancer Screening: A Strategy Combining Rh-Doped SrTiO3-Assisted Laser Desorption/Ionization Mass Spectrometry and Machine Learning

Developing Urinary Metabolomic Signatures As Early Bladder Cancer Diagnostic Markers

Construction of a Ternary Component Chip with Enhanced Desorption Efficiency for Laser Desorption/ionization Mass Spectrometry Based Metabolic Fingerprinting

Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS

Raspberry-like Polymer@au As Matrix in Mass Spectrometry for Urine Metabolic Fingerprinting

Detecting Urine Metabolites of Bladder Cancer by Surface-Enhanced Raman Spectroscopy.

High-Precision Automated Workflow for Urinary Untargeted Metabolomic Epidemiology